137 related articles for article (PubMed ID: 17693405)
21. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
Zaika AI; Slade N; Erster SH; Sansome C; Joseph TW; Pearl M; Chalas E; Moll UM
J Exp Med; 2002 Sep; 196(6):765-80. PubMed ID: 12235210
[TBL] [Abstract][Full Text] [Related]
22. Active transcription of the human FAS/CD95/TNFRSF6 gene involves the p53 family.
Schilling T; Schleithoff ES; Kairat A; Melino G; Stremmel W; Oren M; Krammer PH; Müller M
Biochem Biophys Res Commun; 2009 Sep; 387(2):399-404. PubMed ID: 19615968
[TBL] [Abstract][Full Text] [Related]
23. SHP-2 tyrosine phosphatase inhibits p73-dependent apoptosis and expression of a subset of p53 target genes induced by EGCG.
Amin AR; Thakur VS; Paul RK; Feng GS; Qu CK; Mukhtar H; Agarwal ML
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5419-24. PubMed ID: 17369354
[TBL] [Abstract][Full Text] [Related]
24. TAp73 protein stability is controlled by histone deacetylase 1 via regulation of Hsp90 chaperone function.
Zhang J; Xu E; Chen X
J Biol Chem; 2013 Mar; 288(11):7727-7737. PubMed ID: 23362263
[TBL] [Abstract][Full Text] [Related]
25. p21/CDKN1A mediates negative regulation of transcription by p53.
Löhr K; Möritz C; Contente A; Dobbelstein M
J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
[TBL] [Abstract][Full Text] [Related]
26. [EFFECT OF ANTI-CANCER DRUG DOXORUBICINE ON CYTOMEGALOVIRUS INFECTED HUMAN FIBROBLASTS].
Fedorova NE; Emelianova SS; Vinogradskaya GR; Chichev EV; Murzakova AV; Kirichenko AA; Verbenko VN; Kushch AA
Tsitologiia; 2015; 57(4):260-8. PubMed ID: 26349243
[TBL] [Abstract][Full Text] [Related]
27. Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression.
Saifudeen Z; Diavolitsis V; Stefkova J; Dipp S; Fan H; El-Dahr SS
J Biol Chem; 2005 Jun; 280(24):23094-102. PubMed ID: 15805112
[TBL] [Abstract][Full Text] [Related]
28. p63 and p73: roles in development and tumor formation.
Moll UM; Slade N
Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
[TBL] [Abstract][Full Text] [Related]
29. RNA-binding Protein PCBP2 Regulates p73 Expression and p73-dependent Antioxidant Defense.
Ren C; Zhang J; Yan W; Zhang Y; Chen X
J Biol Chem; 2016 Apr; 291(18):9629-37. PubMed ID: 26907686
[TBL] [Abstract][Full Text] [Related]
30. Negative autoregulation of p73 and p53 by DeltaNp73 in regulating differentiation and survival of human neuroblastoma cells.
Nakagawa T; Takahashi M; Ozaki T; Watanabe K; Hayashi S; Hosoda M; Todo S; Nakagawara A
Cancer Lett; 2003 Jul; 197(1-2):105-9. PubMed ID: 12880968
[TBL] [Abstract][Full Text] [Related]
31. Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia.
Tonino SH; Mulkens CE; van Laar J; Derks IA; Suo G; Croon-de Boer F; van Oers MH; Eldering E; Wang JY; Kater AP
Leuk Lymphoma; 2015; 56(8):2439-47. PubMed ID: 25511680
[TBL] [Abstract][Full Text] [Related]
32. TAp73 is required for spermatogenesis and the maintenance of male fertility.
Inoue S; Tomasini R; Rufini A; Elia AJ; Agostini M; Amelio I; Cescon D; Dinsdale D; Zhou L; Harris IS; Lac S; Silvester J; Li WY; Sasaki M; Haight J; Brüstle A; Wakeham A; McKerlie C; Jurisicova A; Melino G; Mak TW
Proc Natl Acad Sci U S A; 2014 Feb; 111(5):1843-8. PubMed ID: 24449892
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional regulation by p53 and p73.
Lokshin M; Tanaka T; Prives C
Cold Spring Harb Symp Quant Biol; 2005; 70():121-8. PubMed ID: 16869745
[TBL] [Abstract][Full Text] [Related]
34. Curcumin induces apoptosis in p53-null Hep3B cells through a TAp73/DNp73-dependent pathway.
Wang J; Xie H; Gao F; Zhao T; Yang H; Kang B
Tumour Biol; 2016 Mar; 37(3):4203-12. PubMed ID: 26490992
[TBL] [Abstract][Full Text] [Related]
35. Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma.
Schilling T; Kairat A; Melino G; Krammer PH; Stremmel W; Oren M; Müller M
Biochem Biophys Res Commun; 2010 Apr; 394(3):817-23. PubMed ID: 20233581
[TBL] [Abstract][Full Text] [Related]
36. DeltaNp73 antisense activates PUMA and induces apoptosis in neuroblastoma cells.
Simões-Wüst AP; Sigrist B; Belyanskaya L; Hopkins Donaldson S; Stahel RA; Zangemeister-Wittke U
J Neurooncol; 2005 Mar; 72(1):29-34. PubMed ID: 15803372
[TBL] [Abstract][Full Text] [Related]
37. p53-Related Transcription Targets of TAp73 in Cancer Cells-Bona Fide or Distorted Reality?
Wang C; Teo CR; Sabapathy K
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079264
[TBL] [Abstract][Full Text] [Related]
38. PLK2 phosphorylates and inhibits enriched TAp73 in human osteosarcoma cells.
Hu ZB; Liao XH; Xu ZY; Yang X; Dong C; Jin AM; Lu H
Cancer Med; 2016 Jan; 5(1):74-87. PubMed ID: 26625870
[TBL] [Abstract][Full Text] [Related]
39. Aurora kinase A inhibition leads to p73-dependent apoptosis in p53-deficient cancer cells.
Dar AA; Belkhiri A; Ecsedy J; Zaika A; El-Rifai W
Cancer Res; 2008 Nov; 68(21):8998-9004. PubMed ID: 18974145
[TBL] [Abstract][Full Text] [Related]
40. Effects of ΔNp73β on cisplatin treatment in colon cancer cells.
Lööf J; Pfeifer D; Ding Z; Sun XF; Zhang H
Mol Carcinog; 2012 Aug; 51(8):628-35. PubMed ID: 21837762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
